123 related articles for article (PubMed ID: 33080701)
1. Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report.
Wang Y; Chen L; Wang Z; Liu S
Medicine (Baltimore); 2020 Oct; 99(42):e22636. PubMed ID: 33080701
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing assisted diagnosis of cervical metastasis in EGFR-mutated lung adenocarcinoma: A case report.
Xu L; Li K; Chen X; Chen B; Li J; Wu L
Thorac Cancer; 2021 Oct; 12(19):2622-2627. PubMed ID: 34505336
[TBL] [Abstract][Full Text] [Related]
3. Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report.
Inagaki Y; Tamiya A; Matsuda Y; Azuma K; Adachi Y; Enomoto T; Kouno S; Taniguchi Y; Saijo N; Okishio K; Atagi S
Medicine (Baltimore); 2020 Oct; 99(42):e22628. PubMed ID: 33080698
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Hu X; Chen W; Li X; Zhao C; Zhang C; Xiong F; Wu H
Ann Palliat Med; 2019 Nov; 8(5):525-531. PubMed ID: 31865717
[TBL] [Abstract][Full Text] [Related]
5. Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation.
Li C; Nie W; Guo J; Xiong A; Zhong H; Chu T; Zhong R; Xu J; Lu J; Zheng X; Zhang B; Shen Y; Pan F; Han B; Zhang X
Respir Res; 2021 May; 22(1):145. PubMed ID: 33975616
[TBL] [Abstract][Full Text] [Related]
6. The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.
Sueoka-Aragane N; Nakashima C; Yoshida H; Matsumoto N; Iwanaga K; Ebi N; Nishiyama A; Yatera K; Kuyama S; Fukuda M; Ushijima S; Umeguchi H; Harada D; Kashiwabara K; Suetsugu T; Fujimoto N; Tanaka F; Uramoto H; Yoshii C; Nakatomi K; Koh G; Seki N; Aoe K; Nosaki K; Inoue K; Takamori A; Kawaguchi A
Cancer Med; 2021 Jun; 10(12):3873-3885. PubMed ID: 33982444
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.
Kunimasa K; Nishino K; Kukita Y; Matsumoto S; Kawachi H; Kawamura T; Inoue T; Tamiya M; Honma K; Sugimoto N; Yamasaki T; Imamura F; Goto K; Kumagai T
Cancer Genet; 2021 Aug; 256-257():57-61. PubMed ID: 33901930
[TBL] [Abstract][Full Text] [Related]
8. A promising response to osimertinib in a patient with erlotinib-resistant lung adenocarcinoma with an uncommon EGFR mutation.
Niwa H; Nakahara Y; Sasaki J; Masuda N
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866661
[TBL] [Abstract][Full Text] [Related]
9. Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients.
Boysen Fynboe Ebert E; McCulloch T; Holmskov Hansen K; Linnet H; Sorensen B; Meldgaard P
Lung Cancer; 2020 May; 143():67-72. PubMed ID: 32213382
[TBL] [Abstract][Full Text] [Related]
10. Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S.
Fanjat Y; Barazzutti H; Di Mauro I; Tabary-Martin L; Duranton-Tanneur V; Gimet S; Bérard H; Pedeutour F
Cancer Genet; 2021 Aug; 256-257():158-161. PubMed ID: 34157597
[TBL] [Abstract][Full Text] [Related]
11. Detection of Meningeal Metastasis in the Cerebrospinal Fluid in Lung Adenocarcinoma: Case Report.
Zhang YJ; Li H; Zhong R; Chen W; Kou G; Liu G; Cheng Y
Clin Lung Cancer; 2020 Sep; 21(5):e493-e496. PubMed ID: 32418825
[No Abstract] [Full Text] [Related]
12. Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.
Schmid S; Stewart EL; Martins-Filho SN; Cabanero M; Wang A; Bao H; Wu X; Patel D; Chen Z; Law JH; Bradbury PA; Shepherd FA; Leighl N; Tsao MS; Pugh T; Bratman SV; Sacher A; Liu G
Clin Lung Cancer; 2020 Sep; 21(5):e488-e492. PubMed ID: 32389504
[No Abstract] [Full Text] [Related]
13. Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival.
Joo JW; Hong MH; Shim HS
Lung Cancer; 2018 Jul; 121():12-17. PubMed ID: 29858020
[TBL] [Abstract][Full Text] [Related]
14. Clinical Efficacy of Osimertinib in a Patient Presenting a Double EGFR L747S and G719C Mutation.
Grolleau E; Haddad V; Boissière L; Falchero L; Arpin D
J Thorac Oncol; 2019 Jul; 14(7):e151-e153. PubMed ID: 31235042
[No Abstract] [Full Text] [Related]
15. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
[TBL] [Abstract][Full Text] [Related]
16. Pilot Study of Dacomitinib for Patients With Metastatic
Choudhury NJ; Makhnin A; Tobi YY; Daly RM; Preeshagul IR; Iqbal AN; Ahn LS; Hayes SA; Heller G; Kris MG; Riely GJ; Yu HA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250398
[TBL] [Abstract][Full Text] [Related]
17. Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
Ikari T; Sakakibara-Konishi J; Yamamoto G; Kitai H; Mizugaki H; Asahina H; Kikuchi E; Shinagawa N
Clin Lung Cancer; 2019 Jul; 20(4):e531-e533. PubMed ID: 31164318
[No Abstract] [Full Text] [Related]
18. Diffuse metastases of lung adenocarcinoma with EGFR mutation.
Kunimasa K; Masuda G; Watanabe N; Ishida T
Intern Med; 2012; 51(6):685-6. PubMed ID: 22449692
[No Abstract] [Full Text] [Related]
19. Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study).
Eide IJZ; Helland Å; Ekman S; Mellemgaard A; Hansen KH; Cicenas S; Koivunen J; Grønberg BH; Brustugun OT
Lung Cancer; 2020 May; 143():27-35. PubMed ID: 32200138
[TBL] [Abstract][Full Text] [Related]
20. Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report.
Fang YF; Liu PC
Thorac Cancer; 2021 Dec; 12(24):3429-3432. PubMed ID: 34729927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
